METABOLIC-FATE OF PARTIALLY DEPOLYMERIZED CHONDROITIN SULFATE ADMINISTERED TO THE RAT

被引:0
|
作者
CONTE, A [1 ]
PALMIERI, L [1 ]
SEGNINI, D [1 ]
RONCA, G [1 ]
机构
[1] UNIV PISA,SCH MED,INST BIOL CHEM,I-56126 PISA,ITALY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Partially depolymerized chondroitin sulfate (dCS) was tritiated and given to rats. With both the intramuscular and oral routes of administration the main route of excretion is urine. More than 40% of the radioactivity is present in tissues 24 h after administration. After intramuscular injection, radioactivity plasma levels rapidly increase with a peak at 0.6 h. The separation of the radioactive material on a Biogel P-4 column shows that the radioactivity in the first hour after injection is mainly constituted of dCS with molecular weight higher than 4000 daltons (dCS > 4000). The composition of the radioactive material changes with time; after 24 h the dCS > 4000 is a few percent of the total radioactivity. A large amount of tritiated water due to exchange and metabolization of dCS is found. Mono-, oligo- and polysaccharides resulting from the breakdown of dCS are also present. After oral administration, plasma radioactivity rapidly increases, with a shoulder and a small peak after 1 h and a large peak after 11 h. A tropism of the radioactivity towards glycosaminoglycan-rich tissues is observed. The presence of dCS > 4000 in plasma, synovia and cartilage after oral and intramuscular administrations of dCS may explain the chondroprotective effect of exogenous dCS. In fact, desulfated and sulfated oligo- and polysaccharides have regulatory effects on the synthesis and breakdown of hyaluronate-proteoglycan complexes of cartilage.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 50 条
  • [1] METABOLIC-FATE OF PARTIALLY DEPOLYMERIZED SHARK CHONDROITIN SULFATE IN MAN
    RONCA, G
    CONTE, A
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1993, 13 : 27 - 34
  • [2] METABOLIC-FATE OF EXOGENOUS CHONDROITIN SULFATE IN MAN
    CONTE, A
    DEBERNARD, M
    PALMIERI, L
    LUALDI, P
    MAUTONE, G
    RONCA, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (07): : 768 - 772
  • [3] METABOLIC-FATE OF EXOGENOUS CHONDROITIN SULFATE IN THE EXPERIMENTAL ANIMAL
    PALMIERI, L
    CONTE, A
    GIOVANNINI, L
    LUALDI, P
    RONCA, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (03): : 319 - 323
  • [4] METABOLIC-FATE OF INTRAVENOUSLY INJECTED PEPTIDE-BOUND CHONDROITIN SULFATE IN RAT
    WOOD, KM
    CURTIS, CG
    POWELL, GM
    WUSTEMAN, FS
    BIOCHEMICAL JOURNAL, 1976, 158 (01) : 39 - 46
  • [5] METABOLIC-FATE OF CHONDROITIN [S-35]SULPHATE PROTEOGLYCAN IN RAT
    WOOD, KM
    WUSTEMAN, FS
    CURTIS, CG
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1975, 3 (04) : 500 - 502
  • [6] THE METABOLIC-FATE OF SUPIDIMIDE IN THE RAT
    BECKER, R
    FRANKUS, E
    GRAUDUMS, I
    GUNZLER, WA
    HELM, FC
    FLOHE, L
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1982, 32-2 (09): : 1101 - 1111
  • [7] METABOLIC-FATE OF HEXOBARBITAL IN RAT
    HOLCOMB, RR
    GERBER, N
    BUSH, MT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1974, 188 (01): : 14 - 26
  • [8] METABOLIC-FATE OF NITROSOPROLINE IN THE RAT
    CHU, C
    MAGEE, PN
    CANCER RESEARCH, 1981, 41 (09) : 3653 - 3657
  • [9] METABOLIC-FATE OF INTRAVENOUSLY ADMINISTERED MALTOSE IN ANIMALS
    FUJIWARA, H
    TSUTSUMI, K
    KAWASHIMA, Y
    JOURNAL OF THE JAPANESE SOCIETY OF STARCH SCIENCE, 1979, 26 (02) : 80 - 89
  • [10] METABOLIC-FATE OF LOXISTATIN IN RAT
    FUKUSHIMA, K
    ARAI, M
    TAMAI, M
    YOKOO, C
    MURATA, M
    SUWA, T
    SATOH, T
    XENOBIOTICA, 1990, 20 (10) : 1043 - 1051